Substance P Administered after Myocardial Infarction Upregulates Microphthalmia-Associated Transcription Factor, GATA4, and the Expansion of c-Kit<sup>+</sup> Cells

<div>A high coexpression of MITF and c-Kit in LV<sup>7daysI/R</sup> and c-LV<sup>7daysSP+I/R</sup>. Confocal images of MITF staining (red fluorescence) in conjunction with c-Kit (green fluorescence) and nuclear staining (blue fluorescence) in sections of LV<sup>7daysI/R</sup> and LV<sup>7daysSP+I/R</sup>. Scale bars, 20 <i>μ</i>m with a further magnified area indicated by the dotted white circle.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Substance P Administered after Myocardial Infarction Upregulates Microphthalmia-Associated Transcription Factor, GATA4, and the Expansion of c-Kit<sup>+</sup> Cells 

Figure 2 | Substance P Administered after Myocardial Infarction Upregulates Microphthalmia-Associated Transcription Factor, GATA4, and the Expansion of c-Kit+ Cells 